Researchers at the Massachusetts Institute of Technology (MIT) have synthesised for the first time a complex fungal compound known as verticillin A, discovered more than 50 years ago and long viewed as a potential anti-cancer agent.
Verticillin A has a highly intricate structure that has made it far more difficult to synthesise than
An Alzheimer’s drug deemed too costly for the National Health Service (NHS) can slow progression of dementia by up to eight years, researchers have claimed.
Medicines assessor NICE ruled in June that the benefits of two breakthrough therapies were too modest to justify the price, after trials showed they could delay progression from
A Global Challenge in Numbers
The progress made in cell therapies to treat the most severe cases of diabetes marks a significant scientific milestone. However, it is important to recognize that while a few thousand transplantation of insulin-producing cells can be life-saving for individual patients, such interventions will have limited
The American Studies Center has awarded the PAIR Prize 2025 in the field of Scientific, Technical and Technological Sciences to Professor Camillo Ricordi, one of the world’s leading researchers in diabetes and regenerative medicine.
Prof. Ricordi’s groundbreaking research has made it possible to understand many of the key
Researchers from Baylor College of Medicine, the Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas Children’s Hospital, Stanford University School of Medicine, and partner institutions have uncovered a new explanation for how exercise promotes weight loss.
Their research revealed that Lac-Phe, a compound
